Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Non Operating Investment Income (2023 - 2025)

Historic Non Operating Investment Income for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $7000.0.

  • Rallybio's Non Operating Investment Income fell 9708.33% to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$145000.0, marking a year-over-year decrease of 13846.15%. This contributed to the annual value of $53000.0 for FY2024, which is 7685.59% down from last year.
  • Per Rallybio's latest filing, its Non Operating Investment Income stood at $7000.0 for Q3 2025, which was down 9708.33% from -$30000.0 recorded in Q2 2025.
  • Over the past 5 years, Rallybio's Non Operating Investment Income peaked at $240000.0 during Q3 2024, and registered a low of -$211000.0 during Q2 2023.
  • Over the past 3 years, Rallybio's median Non Operating Investment Income value was -$7000.0 (recorded in 2025), while the average stood at $23800.0.
  • Over the last 5 years, Rallybio's Non Operating Investment Income had its largest YoY gain of 27500.0% in 2024, and its largest YoY loss of 15620.92% in 2024.
  • Quarter analysis of 3 years shows Rallybio's Non Operating Investment Income stood at $223000.0 in 2023, then plummeted by 145.29% to -$101000.0 in 2024, then soared by 106.93% to $7000.0 in 2025.
  • Its Non Operating Investment Income was $7000.0 in Q3 2025, compared to -$30000.0 in Q2 2025 and -$21000.0 in Q1 2025.